Applications including "octadecyl"

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC InertSearch InertSustain AQ-C18
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustainC18
LC107 - Analysis of Terbinafine hydrochloride (Under the Condition of USP41-NF36,Terbinafine Tablets, IMPURITIES (LIMIT OF TERBINAFINE DIMER)) -

LC InertSearch Inertsil Hybrid-C18
LC106 - Analysis of Sodium Dodecyl Sulfate(Sodium lauryl sulfate) -

LC InertSearch InertSustain C18
LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -

LC InertSearch InertSustainSwift C18
LC101 - Analysis of Fungicides(Under the Condition of food additive analysis method in food, o-Phenylphenol, Sodium o-Phenylphenate, Diphenyl and Thiabendazole) -

LC InertSearch Inertsil ODS-3
LL043 - Analysis of Azithromycin (Based on the Condition of USP-NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -

LC InertSearch Inertsil Hybrid-C18
LC097 - Analysis of Azithromycin (Based on the Condition of USP NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -

LC InertSearch Inertsil Hybrid-C18
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC InertSearch InertSustainSwift C18
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC InertSearch InertSustainSwift C18
LC094 - Analysis of Steroids -

LC InertSearch Inertsil Hybrid-C18
LC093 - Analysis of Phytosterols -

LC InertSearch Inertsil Hybrid-C18
LC092 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC091 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC090 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC089 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC088 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC087 - Analysis of Coenzyme A (CoA) -

LC InertSearch Inertsil Hybrid-C18
LC086 - Analysis of Antiviral drugs -

LC InertSearch Inertsil Hybrid-C18
LC085 - Analysis of Antiviral drug nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC084 - Analysis of Antihistamines -

LC InertSearch Inertsil Hybrid-C18
LC083 - Analysis of Antidepressants -

LC InertSearch Inertsil Hybrid-C18
LC082 - Analysis of phytosterols -

LC InertSearch InertCore Plus C18
LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC InertSearch InertSustain C18
LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC InertSearch InertSustain C18
LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

LC InertSearch Inertsil ODS-3
LC066 - Analysis of Cidofovir (Under the Condition of USP43-NF38, Cidofovir, ASSAY) -

LC InertSearch Inertsil Hybrid-C18
LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -

LC InertSearch InertSustain C18
LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC InertSearch InertSustainSwift C18
LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC InertSearch InertSustainSwift C18
LC062 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin, DISSOLUTION) -

LC InertSearch Inertsil Hybrid-C18
LC061 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin,ASSAY) -

LC InertSearch Inertsil Hybrid-C18
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -

LC InertSearch InertSustainSwift C18
LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC InertSearch InertSustain C18
LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC InertSearch InertSustain C18
LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC InertSearch InertSustain AQ-C18
LC050 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) -

LC InertSearch Inertsil WP300 C18
LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -

LC InertSearch InertSustain C18
LC047 - Analysis of Homocysteine -

LC InertSearch InertSustain AQ-C18
LC045 - Analysis of Catecholamines -

LC InertSearch Inertsil ODS-4
LC044 - Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) -

LC InertSearch InertSustainSwift C18
LC043 - Analysis of Semaglutide and Tirzepatide -

LC InertSearch InertSustainSwift C18
LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -

LC InertSearch InertSustain C18
LC038 - Analysis of Brilliant Green and Methylene Blue -

LC InertSearch InertSustain C18
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC InertSearch InertSustain C18
LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

LC InertSearch InertSustain C18
LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC InertSearch InertSustain C18
LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC InertSearch InertSustain C18
LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC InertSearch InertSustain C18
LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC InertSearch InertSustain C18
LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC InertSearch InertSustain C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC InertSearch InertSustain C18
LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC InertSearch Inertsil ODS-HL
LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC InertSearch InertSustain C18
LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC InertSearch InertSustain C18
LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC InertSearch InertSustain C18
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC InertSearch InertSustain C18
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC InertSearch InertSustainSwift C18
LC013 - Analysis of Bleomycin sulfate -

LC InertSearch InertSustain AQ-C18
LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC InertSearch Inertsil ODS-3
LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch Inertsil ODS-3
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch InertSustain C18
LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC InertSearch Inertsil ODS-3
LC005 - Carbamazepine -

LC InertSearch InertSustainSwift C18
LC004 - Analysis of Urea and Thiourea -

LC InertSearch InertSustain AQ-C18
LC002 - Analysis of Phenazopyridine hydrochloride -

LC InertSearch InertSustain C18
LB991 - Analysis of Progestrone and Methyltestrone -

LC InertSearch Inertsil WP300 C18
LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB986 - Analysis of Ganciclovir -

LC InertSearch Inertsil ODS-3
LB985 - Analysis of Sumatriptan -

LC InertSearch Inertsil ODS-3
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB983 - Analysis of Lornoxicam -

LC InertSearch Inertsil ODS-4
LB982 - Analysis of Ofloxacin -

LC InertSearch InertSustain C18
LB981 - Analysis of Ofloxacin -

LC InertSearch Inertsil WP300 C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB979 - Analysis of Desloratadine -

LC InertSearch InertSustain Cyano
LB978 - Analysis of Hydrochlorothiazide -

LC InertSearch InertSustain AQ-C18
LB977 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain AQ-C18
LB976 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB975 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB974 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB973 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB972 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB971 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB970 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB969 - Analysis of Acyclovir -

LC InertSearch InertSustainSwift C18
LB968 - Analysis of Acyclovir -

LC InertSearch Inertsil WP300 C18
LB967 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB962 - Analysis of β-carotene -

LC InertSearch InertSustainSwift C18
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB959 - Analysis of Food Dyes -

LC InertSearch InertSustainSwift C18
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB954 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LC InertSearch InertSustain C18
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LC InertSearch InertSustain C18
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LC InertSearch InertSustain C18
LB949 - Analysis of Panose -

LC InertSearch Inertsustain NH2
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB944 - Analysis of Amikacin sulfate -

LC InertSearch InertSustainSwift C18
LB943 - Analysis of Amikacin -

LC InertSearch InertSustainSwift C18
LB942 - Analysis of Maleic acid -

LC InertSearch Inertsil ODS-4
LB941 - Analysis of Fumaric acid -

LC InertSearch Inertsil ODS-4
LB940 - Analysis of DL-Malic acid -

LC InertSearch InertSustain C18
LB938 - Analysis of Galantamine -

LC InertSearch InertSustain C18
LB937 - Analysis of Febuxostat -

LC InertSearch Inertsil ODS-4
LB935 - Analysis of Febuxostat -

LC InertSearch InertSustain AQ-C18
LB934 - Analysis of Methylpyrazines -

LC InertSearch InertSustain C18
LB933 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil WP300 C18
LB932 - Analysis of 13 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-HL
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB930 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB929 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB928 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB927 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB926 - Analysis of Piperacillin Sodium -

LC InertSearch Inertsil WP300 C18
LB922 - Analysis of 4 Drugs -

LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18
LB921 - Analysis of 4 Drugs -

LC InertSearch Inertsil ODS-4
LB920 - Analysis of Triphenylphosphine oxide -

LC InertSearch InertSustain C18
LB919 - Analysis of Pitavastatin Calcium -

LC InertSearch InertCore Plus C18
LB918 - Analysis of d-α-Tocopheryl Acetate -

LC InertSearch InertSustain C18
LB917 - Analysis of 130 Pestisides -

LC InertSearch InertSustain C18
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB910 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB909 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB908 - Analysis of Fatty acids (C1-C18) -

LC InertSearch InertSustain AQ-C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA355 - Analysis of Amines -

GC InertSearch InertCap 1
GA354 - Analysis of Amines -

GC InertSearch InertCap for Amines
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain AQ-C18
LB897 - Analysis of Thiamine Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB894 - Analysis of Ursodiol -

LC InertSearch Inertsil WP300
LB893 - Analysis of PAHs -

LC InertSearch Inertsil ODS-P
LB892 - Analysis of Chlorophenols -

LC InertSearch InertSustain C18 HP
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -

LC InertSearch InertSustain AX-C18
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB868 - Analysis of Propionic Acid -

LC InertSearch InertSustain C18
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB866 - Analysis of Sucralose -

LC InertSearch InertSustain C18
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -

LC InertSearch InertSustain C18
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain C18
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -

LC InertSearch InertSustain C18
LB862 - Analysis of Antioxidants -

LC InertSearch InertSustain C18
LB860 - Analysis of Glycyrrhizinate acid -

LC InertSearch InertSustain C18
LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LC InertSearch Inertsil ODS-3
LB858 - Analysis of Natamycin (Analytical Method B) -

LC InertSearch InertSustain C18
LB857 - Analysis of Natamycin (Analytical Method A) -

LC InertSearch InertSustain AQ-C18
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C30
LB854 - Analysis of Naringin and Hesperidin -

LC InertSearch InertSustain AQ-C18
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB852 - Analysis of Benzoic acid -

LC InertSearch InertSustain C18
LB851 - Analysis of Calcium Pantothenate -

LC InertSearch InertSustain AQ-C18
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB846 - Analysis of Tocopheryl acetate -

LC InertSearch InertSustain C18
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -

LC InertSearch InertSustain C18
LB836 - Analysis of Sudan dyes and Para red -

LC InertSearch Inertsil ODS-3
LB835 - Analysis of Sudan dyes and Para red -

LC InertSearch InertSustain C18
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB833 - Analysis of Methyl Parahydroxybenzoate -

LC InertSearch InertSustain C18
LB832 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB831 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB830 - Analysis of Azoxystrobin -

LC InertSearch InertSustain C18
LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB828 - Analysis of Chloroprocaine Hydrochloride -

LC InertSearch InertSustain C18
LB827 - Analysis of Clobetasone butyrate standard -

LC InertSearch InertSustainSwift C18
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB818 - Analysis of Nucleotides and Cyclic nucleotides -

LC InertSearch InertSustain AX-C18
LB809 - Analysis of ATP related compounds and Guanylic acid -

LC InertSearch InertSustain AQ-C18
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB805 - Analysis of nonvolatile amines (prelabel derivatization by Dansyl Chloride) -

LC InertSearch InertSustain C18
LB802 - Analysis of Sesamin -

LC InertSearch Inertsil ODS-HL
LB800 - Analysis of 1,3-Dicyclohexylurea -

LC InertSearch InertSustain C18
LB789 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB788 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB787 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB786 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB785 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain AX-C18
LB784 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB783 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB782 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB781 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB780 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB777 - Analysis of Sugar Phosphates -

LC InertSearch InertSustain AX-C18
LB776 - Analysis of Sugar Phosphates -

LC InertSearch InertSustain AX-C18
LB775 - Analysis of Cyclic Nucleotide -

LC InertSearch InertSustain AX-C18
LB774 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain AX-C18
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -

LC InertSearch InertSustain AX-C18
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB766 - Analysis of Glucuronic acid -

LC InertSearch InertSustain AX-C18
LB765 - Analysis of Sialic acid -

LC InertSearch InertSustain AX-C18
LB764 - Analysis of Organic acids -

LC InertSearch InertSustain AX-C18
LB763 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LT133 - How to Use Preparative HPLC - Part 1 Evaluation of loading amount -

LC Technical Note
LT124 - Analysis of Furfural in Insulating Oil -

LC Technical Note InertSustainSwift C18 InertSustain AQ-C18
GT047 - Easy and fast Enrichment of the Aroma Components of Cheese by MMSE -

GC Technical Note InertCap Pure-WAX

Applications including "octadecyl"

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC107 - Analysis of Terbinafine hydrochloride (Under the Condition of USP41-NF36,Terbinafine Tablets, IMPURITIES (LIMIT OF TERBINAFINE DIMER)) -

LC106 - Analysis of Sodium Dodecyl Sulfate(Sodium lauryl sulfate) -

LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -

LC101 - Analysis of Fungicides(Under the Condition of food additive analysis method in food, o-Phenylphenol, Sodium o-Phenylphenate, Diphenyl and Thiabendazole) -

LL043 - Analysis of Azithromycin (Based on the Condition of USP-NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -

LC097 - Analysis of Azithromycin (Based on the Condition of USP NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -

LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC094 - Analysis of Steroids -

LC093 - Analysis of Phytosterols -

LC092 - Analysis of Oligonucleotides -

LC091 - Analysis of Oligonucleotides -

LC090 - Analysis of Oligonucleotides -

LC089 - Analysis of Nucleobases and Nucleosides -

LC088 - Analysis of Nucleobases and Nucleosides -

LC087 - Analysis of Coenzyme A (CoA) -

LC086 - Analysis of Antiviral drugs -

LC085 - Analysis of Antiviral drug nucleosides -

LC084 - Analysis of Antihistamines -

LC083 - Analysis of Antidepressants -

LC082 - Analysis of phytosterols -

LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

LC066 - Analysis of Cidofovir (Under the Condition of USP43-NF38, Cidofovir, ASSAY) -

LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -

LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC062 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin, DISSOLUTION) -

LC061 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin,ASSAY) -

LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -

LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC050 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) -

LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -

LC047 - Analysis of Homocysteine -

LC045 - Analysis of Catecholamines -

LC044 - Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) -

LC043 - Analysis of Semaglutide and Tirzepatide -

LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -

LC038 - Analysis of Brilliant Green and Methylene Blue -

LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC013 - Analysis of Bleomycin sulfate -

LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC005 - Carbamazepine -

LC004 - Analysis of Urea and Thiourea -

LC002 - Analysis of Phenazopyridine hydrochloride -

LB991 - Analysis of Progestrone and Methyltestrone -